Literature DB >> 18505747

Cyclooxygenase-2 in cancer and angiogenesis.

Mehmet Sahin1, Emel Sahin, Saadet Gümüslü.   

Abstract

Tumor angiogenesis is a process where new blood vessels are formed from preexisting ones, resulting in several pathologies. Solid tumors induce angiogenesis to obtain the required nutrients and oxygen. Otherwise, tumors do not grow beyond 2 to 3 mm in diameter. Cyclooxygenase-2, an inducible enzyme important in inflammation, catalyzes the production of prostanoids from arachidonic acid. Cyclooxygenase-2 plays an important role in several cancer types, including colorectal, gastric, prostate, breast, lung, and endometrial cancer. Besides, cyclooxygenase-2 has been implicated in the progression and angiogenesis of cancers. Cyclooxygenase-2 inhibitors have been used to block angiogenesis and tumor proliferation. In this review, the recent studies related to the role of cyclooxygenase-2 in several cancer types and tumor-induced angiogenesis were compiled.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505747     DOI: 10.1177/0003319708318378

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  32 in total

Review 1.  Part 2: pharmacogenetic variability in drug transport and phase I anticancer drug metabolism.

Authors:  Maarten J Deenen; Annemieke Cats; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2011-05-31

2.  Prostaglandin E2 Reverses the Effects of DNA Methyltransferase Inhibitor and TGFB1 on the Conversion of Naive T Cells to iTregs.

Authors:  Mehmet Sahin; Emel Sahin
Journal:  Transfus Med Hemother       Date:  2019-09-19       Impact factor: 3.747

3.  Anticancer activity of a cyclooxygenase inhibitor, CX9051, in human prostate cancer cells: the roles of NF-kappaB and crosstalk between the extrinsic and intrinsic apoptotic pathways.

Authors:  Chiung-Hua Huang; Jih-Hwa Guh; Grace Shiahuy Chen; Pin-Hsuan Lu; Ji-Wang Chern
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-06-08       Impact factor: 3.000

Review 4.  Posttranscriptional regulation of cancer traits by HuR.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-06       Impact factor: 9.957

5.  A new cyclo-oxygenase-2 gene variant in the Han Chinese population is associated with an increased risk of gastric carcinoma.

Authors:  Yumin Li; Wenting He; Tao Liu; Quanbao Zhang
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

6.  Role of MSK1 in the malignant phenotype of Ras-transformed mouse fibroblasts.

Authors:  Beatriz Pérez-Cadahía; Bojan Drobic; Paula S Espino; Shihua He; Soma Mandal; Shannon Healy; James R Davie
Journal:  J Biol Chem       Date:  2010-11-10       Impact factor: 5.157

7.  Gastric cancer cells inhibit natural killer cell proliferation and induce apoptosis via prostaglandin E2.

Authors:  Tuanjie Li; Qi Zhang; Yuming Jiang; Jiang Yu; Yanfeng Hu; Tingyu Mou; Guihua Chen; Guoxin Li
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

8.  Enhanced Anti-Angiogenic Effect of Low Molecular Weight Heparin-Bile Acid Conjugates by Co-Administration of a Selective COX-2 Inhibitor.

Authors:  Ji-Young Kim; Seung Woo Chung; Sang Yoon Kim; Youngro Byun
Journal:  Pharm Res       Date:  2015-01-15       Impact factor: 4.200

9.  Fenretinide reduces angiogenesis by downregulating CDH5, FOXM1 and eNOS genes and suppressing microRNA-10b.

Authors:  Elif Isil Yücel; Mehmet Sahin
Journal:  Mol Biol Rep       Date:  2020-01-10       Impact factor: 2.316

10.  Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patients.

Authors:  Kailash Mosalpuria; Carolyn Hall; Savitri Krishnamurthy; Ashutosh Lodhi; D Michael Hallman; Mary S Baraniuk; Anirban Bhattacharyya; Anthony Lucci
Journal:  Mol Clin Oncol       Date:  2014-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.